GPT and metabolic dysfunction-associated steatohepatitis: The ALT level of NASH patients treated with pioglitazone are lower than those received the placebo or conventional treatments [Z = 3.69, P = .0002, MD = −11.76, 95% CI: (−18.01 to −5.51)], as shown in Figure 6.